EMS Ltd: consolidated PAT down 59% YoY to ₹15.5 Cr, revenue -34% despite QoQ rebound

EMS Ltd's consolidated PAT fell 59.3% YoY to ₹15.49 Cr (from ₹38.06 Cr in Q1 FY26) as consolidated revenue dropped 34.2% YoY to ₹157.24 Cr (from ₹238.89 Cr). Standalone tells the same story: PAT down 59.8% YoY to ₹15.03 Cr on revenue down 40.5% YoY. The QoQ numbers the company's own press release headlines — consolidated PAT +171% and revenue +30.5% versus Q4 FY26 — are real, but they are a bounce off a depressed Q4 base (₹5.71 Cr PAT, ₹120.50 Cr revenue) that management itself had called disappointing; on the more meaningful year-on-year basis this is a clear decline, not the growth story the release frames it as.

The decline is concentrated in the core contracting segment: segment revenue nearly halved YoY, to ₹129.45 Cr from ₹217.19 Cr, while the smaller flex-sheet/paper manufacturing unit grew (₹27.79 Cr vs ₹21.70 Cr) but is too small to offset it. Margins compressed in step — consolidated NPM fell to ~9.9% from ~15.9% a year ago, and OPM to ~17.9% from ~22.7% — consistent with slower billing/execution on ongoing sewerage and water-infrastructure works rather than any pricing or one-off issue (none flagged, and none evident in the accounts).

The stock went into the print at ₹381.25, down 11.2% over the past month of trading.

No exceptional items in either period — accounts tie out exactly (PBT less tax equals reported PAT, standalone and consolidated)

Against the guidance on record from the company's Q3 FY26 concall (Feb 2026) — "strong growth and recovery anticipated from Q1 FY27," FY26 PAT margin above 15%, and an order book target of ₹3,000 Cr by Q1 FY27 — this print is a miss on every count: order book stood at ₹2,328.91 Cr as of 30 June 2026, and NPM is well under the 15% bar. However, it is broadly consistent with more cautious commentary management gave on the subsequent Q4 FY26 call, where it flagged that Q1 FY27 was not expected to be strong and that PAT margin normalization to 15-17% would take a further 2-3 quarters as accumulated unbilled work-in-progress clears — this quarter reads as roughly on that (lowered) track. No sell-side estimates for this small-cap name were found, so vs-street is unknown. Management's FY27 target, per that same Q4 call, is ₹1,000 Cr consolidated revenue; Q1's ₹157.24 Cr is only ~16% of that, implying a large ramp is still needed through the rest of the year.